A Study Using Flash Glucose Measurements for a New Once-weekly Insulin (Insulin Icodec) in People With Type 2 Diabetes Who Have Not Used Insulin Before (ONWARDS 9)
Public ClinicalTrials.gov record NCT05823948. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Study to Evaluate Flash Glucose Monitoring Based Titration of Once-weekly Insulin Icodec in Insulin-naïve Participants With Type 2 Diabetes
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This study looks at how a person with type 2 diabetes can be treated with insulin icodec and a flash glucose monitor (a small sensor inserted under the skin to measure blood sugar all the time). The study will look at how well insulin icodec controls blood sugar when used in combination with a flash glucose monitor. Participants will get insulin icodec that they have to inject once a week on the same day of the week. The insulin will be injected with a needle in a skin fold in the thigh, upper arm, or stomach. The study will last for about 8 months. Participants will have to wear a flash glucose monitor throughout the study. This is a sensor that fits on arm. Participants will be asked to use a commercially available app called LibreView to allow team to view flash glucose monitor data. Participants will get a study phone to scan the flash glucose monitor 4 times daily and they will be able to see all of the flash glucose monitor data during the study. Women cannot take part if pregnant, breast-feeding or planning to get pregnant during the study period.
Study identification
- NCT ID
- NCT05823948
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 51 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Apr 10, 2023
- Primary completion
- Mar 5, 2024
- Completion
- Apr 10, 2024
- Last update posted
- Apr 29, 2026
2023 – 2024
United States locations
- U.S. sites
- 20
- U.S. states
- 11
- U.S. cities
- 18
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Desert Oasis Hlthcr Med Group | Palm Springs | California | 92262 | — |
| Clinical Trials Research_Sacramento_0 | Sacramento | California | 95821 | — |
| San Diego Family Care | San Diego | California | 92111 | — |
| Mills-Peninsula Hlth Services | San Mateo | California | 94401 | — |
| Florida Inst For Clin Res LLC | Orlando | Florida | 32825 | — |
| Metabolic Research Institute Inc | West Palm Beach | Florida | 33401 | — |
| East West Med Res Inst | Honolulu | Hawaii | 96814 | — |
| Northern Pines Hlth Ctr, PC | Buckley | Michigan | 49620 | — |
| International Diabetes Center | Minneapolis | Minnesota | 55416 | — |
| Palm Research Center Inc-Vegas | Las Vegas | Nevada | 89148 | — |
| Accellacare_NC | Wilmington | North Carolina | 28401 | — |
| Diabetes & Endocrinology Asso | Canton | Ohio | 44718 | — |
| AM Diabetes And Endocrinology | Bartlett | Tennessee | 38133 | — |
| Amarillo Medical Specialists | Amarillo | Texas | 79124 | — |
| Velocity Clin Res, Dallas | Dallas | Texas | 75230 | — |
| UT Southwestern Med Cntr | Dallas | Texas | 75390-9302 | — |
| Fmc Science, Llc | Lampasas | Texas | 76550 | — |
| Clinical Trials of Texas Inc | San Antonio | Texas | 78229 | — |
| Northeast Clinical Research of San Antonio | San Antonio | Texas | 78233 | — |
| Chrysalis Clinical Research | St. George | Utah | 84790 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT05823948, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Apr 29, 2026 · Synced Sep 2, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT05823948 live on ClinicalTrials.gov.